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Objectives. Resistin is a member of cysteine-rich molecules. Several studies have been carried out to determine the biological eﬀect
of resistin, nevertheless a signiﬁcant number are animal studies. All the studies performed regarding the relationship between
serumresistinandobesity were merely accomplishedin women.To the best ofourknowledge, there isnosurvey onthecorrelation
of the serum resistin level and obesity in male children. The aim of the present study is to assess serum concentration of resistin in
obese male children. Methods.Between June 2009 and January 2010, we enrolled 42 randomlyselected obese male students (body
mass index (BMI) >95th percentile, age 15.7 ± 1.5). Thirty-eight healthy age-matched male students with normal BMI (<85th
percentile) were selected asa control group forthe purpose of comparisonof theserum resistin levels. Results. Serum resistinlevels
were measured in obese and control group. No signiﬁcant diﬀerence was found between resistin levels of the 2 groups (obese:
9.21±5.6ng/mLversusnormal:9.83±4.3ng/mL;P = .582).There wasnosigniﬁcantcorrelation between serum resistin level and
BMI. Assessing the resistin level in male subjects was the distinct feature of our study. The outstanding ﬁnding of this research is
that there is no correlation between serum resistin level and obesity. Conclusion.W eha v ed e monstrat e dthatthe r eisnoc orr e lation
between obesity in malechildren andresistin level. Consequently, metabolic abnormalitiesofinsulin resistance seen in obese male
patients are not related to resistin.
1.Introduction
Adipose tissue, involved in control of metabolism, is an
active endocrine organ that secrets a number of hormones
and cytokines termed adipocytokines [1–3]. These include
leptin, interleukin-6, tumor necrosis factor-α, adiponectin,
andresistin [2–10].Adipocytokineshavediﬀerenteﬀectsand
act through autocrine, paracrine, and endocrine pathways
[11–14]. Having been recently identiﬁed as a novel adipocy-
tokines, resistin is a members of cysteine-rich molecules
[1]. Several studies have been carried out to determine the
biologicaleﬀectofresistin;nevertheless,asigniﬁcantnumber
of them have been animal studies. Recently, animal studies
have shown that the serum resistin level remarkably rises
in obese mice and that it may be a harbinger for insulin
resistance and diabetes. Despite the fact that widespread
research has been conducted to ﬁgure out the relationship
between serum resistin and obesity, this issue still remains
debated. One recent study evaluated serum resistin level
in polycystic ovary syndrome, a metabolic disease linked
with insulin resistance and obesity in women [15]. To
the best of our knowledge, there are very limited surveys
on the correlation of serum resistin level and obesity in
children. The aim of the present study was to assess serum
concentration of resistin in obese male children.
2.Materialsand Methods
2.1. Study Population. Between June 2009 and January 2010,
we enrolled 42 randomly selected obese male students (body
mass index (BMI) >95th percentile, age 15.7 ± 1.5). Thirty-
eight healthy age-matched male students with normal BMI
(<85th percentile) were selected as a control group for the
purpose of comparison of the serum resistin levels. Clinical
history with thorough physical examination was performed
in all subjects. Written informed consent was obtained
from all students’ parents before participation in the study.2 Journal of Obesity
Subjects with the following characteristics were excluded
from the study: (1) any pathological or suspicious clinical
abnormality in history or physical examination (other than
simple obesity), (2) short stature (height for age <10th
percentile), (3) acute illness, and (4) abnormal laboratory
data. The study protocol was approved by the local ethics
committee.
2.2. Measurement of Serum Resistin. Blood samples were
o b t a i n e da n ds t o r e da t−70◦C until analysis. Serum resistin
concentration was measured using a Human Resistin ELISA
kit (EIA-4572, DRG instruments GmbH, Germany) in the
Endocrinology and Metabolism Research Laboratory.
2.3. Statistical Analysis. All values are presented as mean ±
SD.Comparisons betweengroupswere made using Student’s
t-test. For all analyses, P-value <.05 was considered as
statistically signiﬁcant.
3.Results
3.1. Subjects Characteristics. Forty-two obese male students
were randomly selected (age: 15.7 ± 1.5yrs; BMI: 30.1 ±
4.3kg/m2). Thirty-eight healthy age-matched male students
with normal BMI (BMI: 18.7 ± 2.5kg/m2) were selected as a
control group. There was a statistically signiﬁcant diﬀerence
between BMI of obese subjects and normal students as
expected (P = .001).
3.2. Serum Resistin Measurements. Serum resistin levels were
measured in obese and control groups. No statistically
signiﬁcant diﬀerence was found between resistin levelsof the
2 groups (obese: 9.21 ± 5.6ng/mL versuscontrol group: 9.83
±4.3ng/mL;P = .582).Therewasnosigniﬁcantcorrelation
between serum resistin level and BMI.
4.Discussion
Secreted by adipocytes, adipocytokines are proteins that play
an important role in the regulation of energy [1, 5, 9].
Adipocytokines include leptin, adiponectin, and resistin [2–
10]. Leptin is a hormone that reduces the appetite and
enhances metabolism [16–18]. It appears that obese people
produce more leptin because of increase in the number
of fat cells [16–18]. Obesity is associated with insulin
resistance, and leptin level is signiﬁcantly correlated with
insulin resistance [16, 17]. Adiponectin, a novel peptide
present speciﬁcally in adipose tissue, has been appreciated
to have inverse correlation with insulin resistance [19].
Resistin was originally recognized as a factor correlating
obesity and diabetes by impairing insulin sensitivity in mice
[1]. Preliminary animal studies put forward that obesity is
associated with increased circulatory resistin concentrations
[1]. Later studies, nonetheless, have determined opposite
results, describing that resistin production goes down in
obese rodents and is suppressed by free fatty acids. All the
studies performed regarding the relationship between serum
resistin and obesity were merely accomplished in women.
Assessing the resistin level in male subjects was the distinct
feature of the present study. The outstanding ﬁnding of this
research is that no correlation between serum resistin level
and obesity was found.
Studiesof resistin showed that resistin gene expression in
3T3-L1adipocyteswasinhibitedbyinsulinandTNF-αwhich
are increased in obesity [20]. Studies of resistin mRNA and
proteinexpressioninadiposetissueofhumanshaveprovided
additional support that resistin may not play a role in obesity
inhumans.Onereportfoundthatisolatedhumanadipocytes
have very low resistin mRNA levels [21].
5.Conclusion
In conclusion, it is demonstrated that there is no correlation
between obesity in male children and resistin level. Conse-
quently,metabolic abnormalitiesof insulin resistance seen in
male obese patients are not related to resistin.
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